Dr. Peter Beitsch on Pertuzumab in Luminal Subtype Breast Cancer OncLive 2:31 8 years ago 422 Скачать Далее
Dr. Peter Beitsch on Pertuzumab in the Luminal Subtype of HER2-Positive Breast Cancer Targeted Oncology 1:28 8 years ago 211 Скачать Далее
Dr. Peter Beitsch on the Benefits of Grouping Patients With Breast Cancer by Subtype for Trials Targeted Oncology 1:03 8 years ago 124 Скачать Далее
Experts Comment, Agendia Breast Cancer Assays - Peter Beitsch, MD Agendia Inc 0:27 11 years ago 556 Скачать Далее
Dr Beitsch says all breast cancer patients deserve genetic testing Pat Whitworth 3:33 6 years ago 37 Скачать Далее
Luminal A vs. Luminal B Breast Cancer: Key Differences Art of Healing Cancer 0:45 1 year ago 1 821 Скачать Далее
Dr. Pat Whitworth on Importance of the Luminal Subtype in Breast Cance Targeted Oncology 1:18 8 years ago 475 Скачать Далее
Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer OncLive 0:47 8 years ago 298 Скачать Далее
Advancing Our Understanding of Basal-Like, Luminal A, and Luminal B Breast Cancers CDMRP 4:55 11 years ago 2 238 Скачать Далее
Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer OncLive 1:53 6 years ago 434 Скачать Далее
Targeted Therapies for Breast Cancer: A Breakthrough in Treatment Cancer Treatment Updates 0:22 4 months ago 258 Скачать Далее
Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer OncLive 1:05 6 years ago 194 Скачать Далее
GRHL2 controlled gene expression networks in luminal breast cancer Research Square 1:37 1 year ago 75 Скачать Далее
Dr. Mittendorf on the Impact of Pertuzumab in HER2+ Breast Cancer OncLive 0:57 6 years ago 193 Скачать Далее
Diseases of Breast: Part 4: Breast carcinoma- risk factors, pathogenesis & classification ilovepathology 13:06 2 years ago 128 065 Скачать Далее
Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast Cancer OncLive 1:13 6 years ago 141 Скачать Далее
Dr. Hurvitz Discusses Role of Pertuzumab in HER2+ Breast Cancer OncLive 1:58 5 years ago 244 Скачать Далее
